CD56, CD57, HBME1, CK19, Galectin-3 and p63 immunohistochemical stains in differentiating diagnosis of thyroid benign/malign lesions and NIFTP
 
Yazarlar (8)
Ebru Taştekin Trakya Üniversitesi, Türkiye
Prof. Dr. Nuray Can Trakya Üniversitesi, Türkiye
Dr. Öğr. Üyesi Nurtaç SARIKAŞ Kastamonu Üniversitesi, Türkiye
Yavuz Atakan Sezer Trakya Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı POLISH JOURNAL OF PATHOLOGY (Q4)
Dergi ISSN 1233-9687 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 01-2019
Cilt / Sayı / Sayfa 70 / 4 / 286–294 DOI 10.5114/PJP.2019.93131
Makale Linki http://dx.doi.org/10.5114/pjp.2019.93131
UAK Araştırma Alanları
Tıbbi Patoloji
Özet
Detection of thyroid carcinoma has been steadily increased in the past few decades. After the recognition of NIFTP, also gain importance to differentiate benign tumors (follicular adenoma) from follicular patterned variants of papillary thyroid carcinoma (invasive and infiltrative follicular variant papillary thyroid carcinoma), and low-risk lesions of thyroid (NIFTP). Follicular patterned proliferations of thyroid still persists as a battle for pathologists. In this study, we aimed to analyze the most commonly used immunohistochemical stains "HBME1, CK19, Galectin-3", adding the new ones "CD56, CD57, and p63". Study groups were; nodular hyperplasia, follicular adenoma, NIFTP, infiltrative follicular variant PTC, classical variant PTC (CVPTC) and follicular carcinoma. Each group consisted of twenty cases. The sections were stained with CD56, CD57, p63, CK19, HBME1 (Mesotel cell), Galectin-3 antibody. Although the expression of CD56 was high in benign follicular lesions, FC could not be excluded in this group. CD57 was high in malignant follicular group and NIFTP. Interestingly, p63 was found highly expressed in FVPTC, which might be promising to predict invasiveness in follicular group of lesions. CK19, Galectin-3 and HBME1 were found quietly prominent in CVPTC in concordance with the previous reports.
Anahtar Kelimeler
thyroid lesions | differential diagnosis | CK19 | Galectin-3 | CD56 | CD57 | p63 | HBME1